Other possibility for the insignificant difference in the level of salivary TNF-α among the three groups and the absence of a correlation between the level of salivary TNF-α among the RA group is that, the DMARD therapy can influence salivary biomarkers of periodontal disease as well as salivary biomarker of RA patients. Here, TNF is linked to rheumatoid arthritis.